| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author Index
|
|
|
|
31 |
S4 |
p. A145-A153
|
artikel
|
| 2 |
EPV093a/#176 A machine learning approach applied to gynecological ultrasound to predict progression-free survival in ovarian cancer patients
|
Arezzo, F.
|
|
|
31 |
S4 |
p. A66
|
artikel
|
| 3 |
EPV280/#317 A bizzare case of ectopic molar pregnancy in broad ligament progressing to GTN
|
Raina, D.
|
|
|
31 |
S4 |
p. A140
|
artikel
|
| 4 |
EPV146/#133 Acceptability of bariatric surgery in young women with endometrial cancer and atypical endometrial hyperplasia: a qualitative study
|
Kim, R.S.
|
|
|
31 |
S4 |
p. A88
|
artikel
|
| 5 |
EPV277/#126 A cross-sectional, non-interventional, multicentric study to determine the prevalence of homologous recombination deficiency among women with newly diagnosed, high-grade, serous or endometrioid ovarian cancer
|
Malaga, C.
|
|
|
31 |
S4 |
p. A139
|
artikel
|
| 6 |
EPV266/#571 ACS NSQIP – personalised risk prediction tool for postoperative complications in gynaeoncology surgery?
|
Sevinyan, L.
|
|
|
31 |
S4 |
p. A134
|
artikel
|
| 7 |
EPV024/#508 Adenoid cystic carcinoma of the breast in Mexican population: experience of 12 years a center of concentration
|
Moreno, G.
|
|
|
31 |
S4 |
p. A39
|
artikel
|
| 8 |
EPV156/#363 Adequacy of information received for patients treated overseas and its impact on continuing treatment and follow-up
|
Alsayed, M.T.
|
|
|
31 |
S4 |
p. A91-A92
|
artikel
|
| 9 |
EPV011/#170 Adjuvant chemotherapy-induced amenorrhea in luminal breast cancer patients: a strong prognostic factor in Tunisian premenopausal women
|
Zribi, A.
|
|
|
31 |
S4 |
p. A34
|
artikel
|
| 10 |
EPV170a/#392 Evaluation of hysteroscopy practice in time of COVID 19 pandemic: a multicenter experience
|
Khedhri, S.
|
|
|
31 |
S4 |
p. A97
|
artikel
|
| 11 |
EPV194/#350 A five years retrospective review study of non -epithelial ovarian cancers in a therithery hospital in Ethiopia sub-sharan country
|
Batu, B.
|
|
|
31 |
S4 |
p. A106-A107
|
artikel
|
| 12 |
EPV003/#326 An integrated genomic, proteomic and immunopeptidomic approach to discover novel tumour neoantigens in an immunologically cold ovarian cancer for personalised T-cell receptor therapy
|
Ho, G.Y.
|
|
|
31 |
S4 |
p. A31
|
artikel
|
| 13 |
EPV052/#273 A novel image-guided point-of-care ethyl cellulose ethanol ablation strategy for recurrent localized cervical cancer
|
Agudogo, J.
|
|
|
31 |
S4 |
p. A50
|
artikel
|
| 14 |
EPV073/#423 An overview of cervical cancer epidemiology at the oncology gynecology center of santa marcelina hospital- Brazil
|
Sanches, S.
|
|
|
31 |
S4 |
p. A58
|
artikel
|
| 15 |
EPV184/#232 An overview of gynecological oncology clinical quality registries worldwide
|
Baldewpersad Tewarie, N.
|
|
|
31 |
S4 |
p. A102
|
artikel
|
| 16 |
EPV267/#604 Applicability of pre-operative patient reported duke activity scale index (DASI) in prediction of postoperative complications in gynaecological oncology
|
Sevinyan, L.
|
|
|
31 |
S4 |
p. A135
|
artikel
|
| 17 |
EPV097/#140 Application of a machine learning algorithm to identify predictors of recurrence and recurrence free survival in high grade endometrial cancer
|
Piedimonte, S.
|
|
|
31 |
S4 |
p. A68
|
artikel
|
| 18 |
EPV296/#395 ‘A prospective multicentric study of risk-reducing salpingo-oophorectomy in brca mutation patients’
|
Spinelli, M.
|
|
|
31 |
S4 |
p. A144
|
artikel
|
| 19 |
EPV278/#248 A randomized controlled phase ii clinical trial of apatinib plus chemotherapy in the first-line(1L) treatment of ivb stage, recurrent or persistent cervical cancer
|
Zhou, Y.
|
|
|
31 |
S4 |
p. A139
|
artikel
|
| 20 |
EPV188/#270 Ascites-derived cortisol correlates with inflammatory and immunosuppressive cytokines in ovarian cancer patients
|
Knochenhauer, H.
|
|
|
31 |
S4 |
p. A103-A104
|
artikel
|
| 21 |
EPV033a/#697 Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
|
Machida, H.
|
|
|
31 |
S4 |
p. A42
|
artikel
|
| 22 |
EPV058/#315 Association of hla-g polymorphisms with high-risk HPV+ cervical pathologies susceptibility
|
Zidi, I.
|
|
|
31 |
S4 |
p. A52
|
artikel
|
| 23 |
EPV250/#600 Associations of healthcare affordability with guideline-adherent surgery among white, black, and hispanic ovarian cancer patients: a u.s national cancer database analysis
|
Ohamadike, O.
|
|
|
31 |
S4 |
p. A127-A128
|
artikel
|
| 24 |
EPV251/#612 Associations of healthcare affordability with utilization of supportive care medication among white, black, and hispanic ovarian cancer patients
|
Ohamadike, O.
|
|
|
31 |
S4 |
p. A128
|
artikel
|
| 25 |
EPV248/#405 A thematic analysis of knowledge and misinformation among cervical cancer radiotherapy patients at a tertiary hospital in South Africa
|
Simonds, H.
|
|
|
31 |
S4 |
p. A127
|
artikel
|
| 26 |
EPV273/#268 Audit of complications in gynaecological onco-surgeries at a tertiary care hospital in South India
|
Veena, P.
|
|
|
31 |
S4 |
p. A137
|
artikel
|
| 27 |
EPV121/#419 Baseline clinical outcomes of lynch syndrome patients undergoing annual surveillance versus risk-reducing surgery in a prospective cohort study
|
Piedimonte, S.
|
|
|
31 |
S4 |
p. A78
|
artikel
|
| 28 |
EPV014/#231 Body image perception in Tunisian women following breast cancer
|
Berrazaga, Y.
|
|
|
31 |
S4 |
p. A35
|
artikel
|
| 29 |
EPV022/#433 Breast cancer screening and the dynamics of age-related incidence and early breast cancer in Kazakhstan
|
Kaidarova, D.
|
|
|
31 |
S4 |
p. A38
|
artikel
|
| 30 |
EPV236/#321 Can midwives efficiently perform cervical cancer screening?
|
Ben Hamida, K.
|
|
|
31 |
S4 |
p. A122
|
artikel
|
| 31 |
EPV181/#221 Carboplatin-based hyperthermic intraperitoneal chemotherapy for managing advanced primary and recurrent ovarian carcinoma – a single-center experience
|
Brault, C.
|
|
|
31 |
S4 |
p. A101
|
artikel
|
| 32 |
EPV282/#442 Case report: choriocarcinoma presented as a vaginal tumor
|
Al -Ansari, A.
|
|
|
31 |
S4 |
p. A140-A141
|
artikel
|
| 33 |
EPV074/#427 Cervical cancer: multicentric epidemiological study
|
Arfaoui, R.
|
|
|
31 |
S4 |
p. A58-A59
|
artikel
|
| 34 |
EPV135/#596 Clinical and pathological features of endometrial cancer patients with dna mismatch repair deficiency treated at a brazilian cancer hospital
|
Mayerhoff, E.
|
|
|
31 |
S4 |
p. A83-A84
|
artikel
|
| 35 |
EPV199/#430 Clinical and survival outcomes of malignant non-dysgerminomatous germ cell tumor of ovary: a single institutional experience of 64 patients
|
Mansouri, H.
|
|
|
31 |
S4 |
p. A108
|
artikel
|
| 36 |
EPV200/#432 Clinical and survival outcomes of pure dysgerminoma of ovary: a single institutional experience of 31 patients
|
Salhi, H.
|
|
|
31 |
S4 |
p. A108-A109
|
artikel
|
| 37 |
EPV025/#546 Clinical-pathological features and treatment modalities in dcis with microinvasion: a Tunisian experience
|
Slim, S.
|
|
|
31 |
S4 |
p. A39
|
artikel
|
| 38 |
EPV164/#428 Clinical significance of mr imaging in the judgment of lymph node metastasis in gynecological malignant tumors
|
Wang, J.
|
|
|
31 |
S4 |
p. A94-A95
|
artikel
|
| 39 |
EPV233/#102 Comparison of localized and intravenous analgesia treatment in women undergoing L.L.E.T.Z under general anesthesia
|
Haran, G.
|
|
|
31 |
S4 |
p. A121
|
artikel
|
| 40 |
EPV062/#354 Comparison of outcomes between abdominal, minimally invasive and combined vaginal- laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian cervical cancer collaborative) study
|
Piedimonte, S.
|
|
|
31 |
S4 |
p. A53-A54
|
artikel
|
| 41 |
EPV027/#553 Concordance in molecular profiles of invasive breast cancer between core needle biopsy and definitive operative specimen analysis
|
Kaabia, O.
|
|
|
31 |
S4 |
p. A40
|
artikel
|
| 42 |
EPV142/#638 Demonstration of a learning curve in the initiation of sentinel lymph node mapping in endometrial cancer in a welsh tertiary gynae cancer centre
|
Rider, L.
|
|
|
31 |
S4 |
p. A86-A87
|
artikel
|
| 43 |
EPV045/#220 Development of a circulating tumor HPV assay for the detection of recurrent cervical cancer
|
Zhang, R.
|
|
|
31 |
S4 |
p. A47
|
artikel
|
| 44 |
EPV283/#72 Development of a gestational trophoblastic neoplasia registry and protocol in an obgyn residency in Rwanda
|
Bazzett-Matabele, L.
|
|
|
31 |
S4 |
p. A141
|
artikel
|
| 45 |
EPV057/#294 Development of a large swine model for anatomical and functional assessment of the female pelvic autonomic nerves in women
|
Mun, J.
|
|
|
31 |
S4 |
p. A52
|
artikel
|
| 46 |
EPV218/#551 Development of a nomogram to predict the feasibility of minimally invasive interval debulking surgery in patients with advanced ovarian cancer: a large monocentric cohort study
|
Conte, C.
|
|
|
31 |
S4 |
p. A115-A116
|
artikel
|
| 47 |
EPV207/#484 Disparate trends in ovarian cancer in Asians living in Asia and the United States
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A111
|
artikel
|
| 48 |
EPV155/#210 Disparities in cervical cancer incidence in native Asians vs. US Asians – a population analysis
|
Moon, A.
|
|
|
31 |
S4 |
p. A91
|
artikel
|
| 49 |
EPV007/#582 DNA damage repair is altered by inhibition of discoidin domain receptor 2 (DDR2) through metabolic rewiring in homologous-recombination proficient ovarian cancer models
|
Stock, E.
|
|
|
31 |
S4 |
p. A33
|
artikel
|
| 50 |
EPV264/#512 Does negative pressure wound therapy reduce surgical site infection in endometrial cancer patients undergoing laparotomy? A multicentre retrospective cohort study
|
Montgomery, A.
|
|
|
31 |
S4 |
p. A133
|
artikel
|
| 51 |
EPV071/#412 Dosimetric study on occult uterine perforation during image-guidance brachytherapy of cervical cancer
|
Zhao, X.
|
|
|
31 |
S4 |
p. A57-A58
|
artikel
|
| 52 |
EPV191/#327 Drug screening of patient-derived organoids from ovarian cancer culture to personalized therapy, an exploratory research
|
Wang, H.
|
|
|
31 |
S4 |
p. A105-A106
|
artikel
|
| 53 |
EPV150/#195 Dynamics of the incidence rates for gynecologic cancer in Uzbekistan
|
Djanklich, S.
|
|
|
31 |
S4 |
p. A89
|
artikel
|
| 54 |
EPV137/#607 Early surgical outcomes of robotic hysterectomy and sentinel lymph node biopsy using indocyanine green (ICG)
|
Iavazzo, C.
|
|
|
31 |
S4 |
p. A84
|
artikel
|
| 55 |
EPV162/#343 Educational value of using case-based, recorded, open-access videomicroscopy in gynecologic pathology
|
Hassell, L.
|
|
|
31 |
S4 |
p. A94
|
artikel
|
| 56 |
EPV271/#98 Effect of surgical modality on the occurrence of vaginal vault dehiscence
|
Lee, Y.J.
|
|
|
31 |
S4 |
p. A136-A137
|
artikel
|
| 57 |
EPV293/#425 Effect on overall survival of cancer program–level variation in the use of neoadjuvant chemotherapy for advanced ovarian cancer: a difference-in-differences study
|
Melamed, A.
|
|
|
31 |
S4 |
p. A143-A144
|
artikel
|
| 58 |
EPV078/#473 Effects of preoperative cervical conization on survival outcomes in patients with early-stage cervical cancer who undergo primary radical hysterectomy: a propensity score matching study
|
Kim, S.I.
|
|
|
31 |
S4 |
p. A60
|
artikel
|
| 59 |
EPV295/#178 Efficacy and tolerability of weekly paclitaxel as ‘salvage therapy’ in patients with gynecological tumors
|
Ligorio, M.
|
|
|
31 |
S4 |
p. A144
|
artikel
|
| 60 |
EPV104/#228 Emerging immunotherapy paradigms in advanced endometrial cancer: the effect of online education on clinician knowledge and confidence
|
Fisher, G.
|
|
|
31 |
S4 |
p. A71
|
artikel
|
| 61 |
EPV012/#171 Endocrine therapy-induced alopecia in patients with breast cancer in Tunisia
|
Zribi, A.
|
|
|
31 |
S4 |
p. A34
|
artikel
|
| 62 |
EPV130/#537 Endometrial cancer (EC): lymphovascular space invasion (LVSI) and lymph node metastasis (LNM) according to molecular subgroups
|
Del Pezzo, C.
|
|
|
31 |
S4 |
p. A81-A82
|
artikel
|
| 63 |
EPV106/#249 Endometrial cancer immunohistochemical risk stratification in a large uterine-confined cancer series
|
Perrone, E.
|
|
|
31 |
S4 |
p. A72
|
artikel
|
| 64 |
EPV107/#258 ENGOT-EN11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer
|
Van Gorp, T.
|
|
|
31 |
S4 |
p. A72-A73
|
artikel
|
| 65 |
EPV289/#657 Epidemiological profile of patients with maligna vulva neoplasia attended at santa marcelina itaquera hospital – Sao Paulo
|
Barbosa, J.A.
|
|
|
31 |
S4 |
p. A143
|
artikel
|
| 66 |
EPV279/#351 EPIK-O/ENGOT-OV61: a phase 3, randomized study of alpelisib + olaparib in patients with no germline brca mutation detected, platinum-resistant or -refractory, high-grade serous ovarian cancer
|
Konstantinopoulos, P.
|
|
|
31 |
S4 |
p. A139-A140
|
artikel
|
| 67 |
EPV036/#142 European network for gynaecological oncological trial (ENGOT)-CX11/gynecologic oncology group (GOG) 3047/keynote-A18: phase 3 trial of pembrolizumab plus chemoradiotherapy in high-risk locally advanced cervical cancer
|
Lorusso, D.
|
|
|
31 |
S4 |
p. A43-A44
|
artikel
|
| 68 |
EPV239/#263 Evaluation of the impact of postoperative adjuvant therapy on survival and recurrence patterns in stage I-IV uterine carcinosarcoma
|
Mceachron, J.
|
|
|
31 |
S4 |
p. A123-A124
|
artikel
|
| 69 |
EPV179/#184 Evaluation of the sensitivity to different chemotherapy regimens in platinum—partial sensitive recurrent ovarian cancer
|
Wang, Y.
|
|
|
31 |
S4 |
p. A100
|
artikel
|
| 70 |
EPV185/#234 Evolving ovarian cancer treatment patterns in the united states from 1982–2018: results from the tempus dataset
|
Szamreta, E.
|
|
|
31 |
S4 |
p. A102
|
artikel
|
| 71 |
EPV095/#104 Examining the risk of colorectal cancer in patients with MLH-1 promoter hypermethylated endometrial cancer
|
Kanbergs, A.
|
|
|
31 |
S4 |
p. A67-A68
|
artikel
|
| 72 |
EPV114/#325 Expression of aquaporins in human endometrial cancer: identification and regulation by ovarian hormones in carcinogenesis of endometrial cancer
|
Khan, S.
|
|
|
31 |
S4 |
p. A75
|
artikel
|
| 73 |
EPV219/#581 Full systematic lymphadenectomy for apparent early stage ovarian cancer: impact on specific lymphatic morbidity
|
Ervas, E.
|
|
|
31 |
S4 |
p. A116
|
artikel
|
| 74 |
EPV262/#462 Functional neovagina formation using vertical rectus abdominis musculocutaneous (VRAM) flap following pelvic exenteration
|
Smyth, S.
|
|
|
31 |
S4 |
p. A132-A133
|
artikel
|
| 75 |
EPV152/#655 Genetic profile by whole exam sequencing of borderline ovarian tumors: series of 32 patients
|
Atallah, D.
|
|
|
31 |
S4 |
p. A90
|
artikel
|
| 76 |
EPV229/#611 ‘Geriatric patients with gynecological cancer; treatment options’
|
Kokkali, K.
|
|
|
31 |
S4 |
p. A120
|
artikel
|
| 77 |
EPV160/#618 Global assessment of guidelines for BRCA1/2 genetic testing: call to action in health equity for women and families at risk for hereditary ovarian cancer
|
Hughes, B.N.
|
|
|
31 |
S4 |
p. A93
|
artikel
|
| 78 |
EPV116/#34 High grade endometrial carcinoma limited to the endometrium or a polyp. Is adjuvant treatment necessary?
|
Dallaire Nantel, L.
|
|
|
31 |
S4 |
p. A76
|
artikel
|
| 79 |
EPV056/#293 High incidences of cervical cancer in us black women over age 65 – should individualized screening guidelines be considered?
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A51-A52
|
artikel
|
| 80 |
EPV013/#172 Histological and molecular particularities of breast cancers in Tunisian population
|
Zribi, A.
|
|
|
31 |
S4 |
p. A35
|
artikel
|
| 81 |
EPV154/#117 HIV testing in cervical dysplasia, practitioners’ opinion
|
van de Laar, R.
|
|
|
31 |
S4 |
p. A91
|
artikel
|
| 82 |
EPV175/#156 Homologous recombination repair genes testing in a cohort of apulian ovarian cancers patients in the routine diagnostic procedure
|
Turchiano, A.
|
|
|
31 |
S4 |
p. A99
|
artikel
|
| 83 |
EPV285/#322 Human leukocyte antigen-g expression in vulvar squamous cell carcinoma
|
Boujelbene, N.
|
|
|
31 |
S4 |
p. A141-A142
|
artikel
|
| 84 |
EPV226/#634 Hyperthermic intraperitoneal chemotherapy with CO2 recirculation system (PRS) after interval debulking surgery in advanced ovarian cancer (AOC): preliminary efficacy results from a phase II study
|
Murgia, F.
|
|
|
31 |
S4 |
p. A118-A119
|
artikel
|
| 85 |
EPV041/#196 Hysterectomy after chemoradiotherapy for locally advanced cervical cancer – evaluation of prognostic factors and survival
|
Almeida De Sousa, T.
|
|
|
31 |
S4 |
p. A45-A46
|
artikel
|
| 86 |
EPV178/#166 Identification of biomarkers and targets for the immunotherapy of patients with clear cell ovarian cancer: a systematic literature review
|
Butler, H.
|
|
|
31 |
S4 |
p. A99-A100
|
artikel
|
| 87 |
EPV238/#131 Impact of lymphadenectomy and intraoperative tumor rupture on survival in early stage mucinous ovarian cancers
|
Kim, R.S.
|
|
|
31 |
S4 |
p. A123
|
artikel
|
| 88 |
EPV217/#534 Impact of residual tumor size by computed tomography after primary optimal cytoreduction on prognosis of advanced ovarian cancer
|
Lim, H.
|
|
|
31 |
S4 |
p. A115
|
artikel
|
| 89 |
EPV221/#599 Implementation and feasibility of prophylactic bilateral salpingectomy at benign, minimally invasive (vaginal and laparoscopic) hysterectomy in styria (Austria)
|
Hütter, C.
|
|
|
31 |
S4 |
p. A117
|
artikel
|
| 90 |
EPV177/#165 Implementation of esgo quality indicators (QI) for ovarian cancer surgery (OCS) in a Latin American center
|
Silva, T.
|
|
|
31 |
S4 |
p. A99
|
artikel
|
| 91 |
EPV102/#216 Implementation of molecular stratification in endometrial cancer through mirnas characterization
|
Perrone, A.M.
|
|
|
31 |
S4 |
p. A70
|
artikel
|
| 92 |
EPV258/#285 Improving the rates of same day discharge in robotic surgery patients – a gynecologic oncology quality improvement project
|
Mateshaytis, J.
|
|
|
31 |
S4 |
p. A130-A131
|
artikel
|
| 93 |
EPV037/#157 Incidence of cervical cancer and the HPV vaccine in the United States: are we seeing results of vaccination efforts?
|
Francoeur, A.
|
|
|
31 |
S4 |
p. A44
|
artikel
|
| 94 |
EPV211/#493 Incomplete cycles of chemotherapy using weekly gemcitabine affecting prognosis of platinum-resistant ovarian cancer
|
Seol, A.
|
|
|
31 |
S4 |
p. A113
|
artikel
|
| 95 |
EPV228/#80 Increased incidence of ovarian cancer in both endometriosis and adenomyosis
|
Hermens, M.
|
|
|
31 |
S4 |
p. A119
|
artikel
|
| 96 |
EPV245/#230 Increasing incidence of ovarian and uterine carcinosarcoma: a United States cancer statistics study
|
Tunnage, I.
|
|
|
31 |
S4 |
p. A125-A126
|
artikel
|
| 97 |
EPV204/#454 Inguinal metastases as presenting sign of ovarian cancer
|
Cataldo, V.
|
|
|
31 |
S4 |
p. A110
|
artikel
|
| 98 |
EPV263/#470 Initial experience with the enhanced recovery after surgery (ERAS) protocol in gynecology at a tertiary academic medical center
|
Noh, J.
|
|
|
31 |
S4 |
p. A133
|
artikel
|
| 99 |
EPV059/#324 Interactive flashcards improve human papillomavirus vaccine knowledge and willingness to recommend among nurses
|
Leung, S.O.A.
|
|
|
31 |
S4 |
p. A52-A53
|
artikel
|
| 100 |
EPV115/#333 Interim analysis of 10-year data regarding presentation and management of uterine carcinosarcoma (UCS) cases across the thames valley cancer alliance network
|
Gkorila, A.
|
|
|
31 |
S4 |
p. A75-A76
|
artikel
|
| 101 |
EPV075/#455 Intraoperative lymph node frozen section examination (FSE) in early stage cervical cancer – a risk stratification algorithm
|
Smyth, S.
|
|
|
31 |
S4 |
p. A59
|
artikel
|
| 102 |
EPV176/#158 Investigating a family of cancer-testis antigens as biomarkers for the earlier detection of ovarian cancer
|
Grayson, K.
|
|
|
31 |
S4 |
p. A99
|
artikel
|
| 103 |
EPV085/#566 Is a ‘catch up’ surgery after chemoradiation therapy for locally advanced cervical cancer still an option?
|
Kaabia, O.
|
|
|
31 |
S4 |
p. A63
|
artikel
|
| 104 |
EPV122/#421 Isolated lymphatic recurrence in endometrial cancer: a retrospective study
|
Garzon, S.
|
|
|
31 |
S4 |
p. A78-A79
|
artikel
|
| 105 |
EPV186/#240 Knowledge about advanced ovarian cancer and maintenance therapy: does experience matter?
|
Basabe, M.
|
|
|
31 |
S4 |
p. A102-A103
|
artikel
|
| 106 |
EPV182/#225 Laparoscopic interval debulking surgery for advanced ovarian cancer-single centre experience
|
Naaman, Y.
|
|
|
31 |
S4 |
p. A101
|
artikel
|
| 107 |
EPV198/#424 Laparoscopic restaging surgery for gynaecological malignancies
|
Puga, O.
|
|
|
31 |
S4 |
p. A108
|
artikel
|
| 108 |
EPV147/#253 Live birth, remission and relapse rates for fertility-preserving treatments of endometrial adenocarcinoma: a systematic review and meta-analysis
|
Oxley, S.
|
|
|
31 |
S4 |
p. A88
|
artikel
|
| 109 |
EPV083/#547 Locally advanced cervical carcinoma (LACC) submitted to chemioradiation followed by surgery: a propensity score analysis of response and survival according to histotype
|
Legge, F.
|
|
|
31 |
S4 |
p. A62
|
artikel
|
| 110 |
EPV129/#529 Long-term clinical and economic value of pembrolizumab + lenvatinib compared with chemotherapy in previously treated advanced endometrial cancer patients in Sweden: a cost-effectiveness analysis
|
Upadhyay, N.
|
|
|
31 |
S4 |
p. A81
|
artikel
|
| 111 |
EPV290/#90 Long-term results of primary vaginal cancer treatment: the Belarus national cancer centre experience
|
Matylevich, O.
|
|
|
31 |
S4 |
p. A143
|
artikel
|
| 112 |
EPV131/#545 Lower uterine segment involvement in high-grade endometrial carcinoma is not independently associated with adverse oncological outcome
|
Brandt, B.
|
|
|
31 |
S4 |
p. A82
|
artikel
|
| 113 |
EPV096/#110 LSR activates mapk pathway and promotes cell proliferation and invasion in endometrial cancer: analysis of bioinformatics-based signal transduction
|
Nagase, Y.
|
|
|
31 |
S4 |
p. A68
|
artikel
|
| 114 |
EPV244/#93 Malignancies in transplant patients: an atypical presentation and course of ovarian carcinoma – a case report
|
Verhaegen, J.
|
|
|
31 |
S4 |
p. A125
|
artikel
|
| 115 |
EPV094/#103 Malignant perivascular epithelioid tumor of the uterus associated with hyperprolactinemia
|
Argel, J.I.
|
|
|
31 |
S4 |
p. A67
|
artikel
|
| 116 |
EPV018/#301 Malignant phyllodes tumors of the breast: patterns of care and predictors of adjuvant radiation therapy
|
Bouaziz, H.
|
|
|
31 |
S4 |
p. A36
|
artikel
|
| 117 |
EPV168/#474 Medical care of patients with gynecologic cancer during the covid-19 pandemic: experience of a cancer center in Brazil
|
Moura, A.
|
|
|
31 |
S4 |
p. A96
|
artikel
|
| 118 |
EPV220/#594 Mesonephric-like mullerian adenocarcinoma of the ovary
|
Michas, A.
|
|
|
31 |
S4 |
p. A116
|
artikel
|
| 119 |
EPV002/#308 Metabolomic adaptations associated with chemoresistance in ovarian cancer cell lines
|
Corey, L.
|
|
|
31 |
S4 |
p. A30-A31
|
artikel
|
| 120 |
EPV136/#605 Metformin use among diabetic women and endometrial cancer survival: an Israeli gynecologic oncology group study
|
Brandt, B.
|
|
|
31 |
S4 |
p. A84
|
artikel
|
| 121 |
EPV005/#536 Molecular analysis of primary endometrial cancer and matched lung metastases
|
Gordhandas, S.
|
|
|
31 |
S4 |
p. A32
|
artikel
|
| 122 |
EPV145/#82 Multicentric predictive score validation for nodal assessment in endometrial cancer patients: preliminary data
|
Capozzi, V.A.
|
|
|
31 |
S4 |
p. A87-A88
|
artikel
|
| 123 |
EPV124/#439 Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer
|
Khaldi, H.
|
|
|
31 |
S4 |
p. A79-A80
|
artikel
|
| 124 |
EPV038/#163 Neurotrophic tyrosine kinase receptor-1 (NTRK-1) rearranged cervical sarcoma with fibrosarcoma like morphology presenting in a 13-year-old managed with a neo-adjuvant trk-inhibitor and surgical excision
|
Goulding, E.
|
|
|
31 |
S4 |
p. A44
|
artikel
|
| 125 |
EPV030/#572 Nutritional status and quality of life of breast cancer patients needing for response to neoadjuvant chemotherapy: about 19 patients
|
Bouhani, M.
|
|
|
31 |
S4 |
p. A41
|
artikel
|
| 126 |
EPV172/#118 Olaparib single- centre experience in relapsed epithelial ovarian cancer in Slovenia
|
Gregorič, B.
|
|
|
31 |
S4 |
p. A98
|
artikel
|
| 127 |
EPV270/#88 Optimizing the screening and management of preoperative anemia prior to gynecologic oncology surgery (OPRA): a quality improvement initiative
|
Spenard, E.
|
|
|
31 |
S4 |
p. A136
|
artikel
|
| 128 |
EPV234/#208 Outcome after loop electrosurgical excision procedure for cervical high-grade squamous intraepithelial lesion
|
Kwok, S.T.
|
|
|
31 |
S4 |
p. A121-A122
|
artikel
|
| 129 |
EPV089/#619 Outcomes after establishment of a pilot cervical cancer navigation program at a tertiary Tanzanian academic hospital
|
Hari, A.
|
|
|
31 |
S4 |
p. A64
|
artikel
|
| 130 |
EPV047/#243 Outcomes of cervical cancer in human immunodeficiency virus (HIV) positive women treated with radiotherapy
|
Mohanty, S.
|
|
|
31 |
S4 |
p. A48
|
artikel
|
| 131 |
EPV242/#497 Outcomes of laterally extended endopelvic resection in pelvic sidewall sarcoma: a single-institution experience
|
Kim, J.
|
|
|
31 |
S4 |
p. A124-A125
|
artikel
|
| 132 |
EPV148/#91 Outcomes of various fertility-sparing options for early cervical cancer patients versus abdominal radical hysterectomy: one cancer center ten-year experience
|
Matylevich, O.
|
|
|
31 |
S4 |
p. A88-A89
|
artikel
|
| 133 |
EPV227/#79 Ovarian cancer incidence after bilateral salpingo-oophorectomy in women with histological proven endometriosis or adenomyosis
|
Hermens, M.
|
|
|
31 |
S4 |
p. A119
|
artikel
|
| 134 |
EPV214/#506 Overall survival prognostic factors in recurrent epithelial ovarian cancer in Tunisia
|
Berrazaga, Y.
|
|
|
31 |
S4 |
p. A114
|
artikel
|
| 135 |
EPV050/#255 Overuse of cervical cancer screening tests among average-risk medicaid beneficiaries
|
Dillon, J.
|
|
|
31 |
S4 |
p. A49
|
artikel
|
| 136 |
EPV031/#576 Paget’s disease of the nipple: with concomitant breast tumor: about 10 cases
|
Bouhani, M.
|
|
|
31 |
S4 |
p. A41
|
artikel
|
| 137 |
EPV183/#227 Parp inhibitors in newly diagnosed advanced ovarian cancer: an assessment of clinical practices
|
Fisher, G.
|
|
|
31 |
S4 |
p. A101
|
artikel
|
| 138 |
EPV023/#441 Pathologic findings in premenopausal patients with receptor-positive metastatic breast cancer undergoing bilateral salpingo-oophorectomy
|
Wagner, M.
|
|
|
31 |
S4 |
p. A38-A39
|
artikel
|
| 139 |
EPV259/#288 Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic oncology surgery: a 5-year single center experience
|
Hayek, J.
|
|
|
31 |
S4 |
p. A131
|
artikel
|
| 140 |
EPV049/#254 Patient-reported lower limb lymphedema and quality of life after radical surgery with sentinel node mapping for early-stage cervical cancer
|
Sponholtz, S.
|
|
|
31 |
S4 |
p. A48-A49
|
artikel
|
| 141 |
EPV117/#36 PD-L1 is a tumor suppressor in aggressive endometrial cancer cells and its expression is regulated by MIR-216A and lncrna MEG3
|
Dong, P.
|
|
|
31 |
S4 |
p. A76
|
artikel
|
| 142 |
EPV240/#380 Pelvic castleman´s disease: a case report
|
Treviño Salinas, E.
|
|
|
31 |
S4 |
p. A124
|
artikel
|
| 143 |
EPV149/#132 Performance characteristics of brief family history questionnaire to screen for lynch syndrome in women with newly diagnosed ovarian cancers
|
Kim, R.S.
|
|
|
31 |
S4 |
p. A89
|
artikel
|
| 144 |
EPV275/#374 Photobiomodulation for radiodermatitis prevention in breast cancer: results from a double blind randomized controlled trial (photodermis trial)
|
Fischer-Sgrott, F.
|
|
|
31 |
S4 |
p. A138
|
artikel
|
| 145 |
EPV017/#299 Phyllodes tumors of the breast: a retrospective analysis of clinicopathological features of local recurrence
|
Bouaziz, H.
|
|
|
31 |
S4 |
p. A36
|
artikel
|
| 146 |
EPV108/#267 Pitfalls in pre-operative prediction of lymph node metastasis in early endometrial cancer
|
Veena, P.
|
|
|
31 |
S4 |
p. A73
|
artikel
|
| 147 |
EPV213/#503 Platinum -sensitive or resistant relapsed ovarian cancer: which predictive factors?
|
Berrazaga, Y.
|
|
|
31 |
S4 |
p. A113-A114
|
artikel
|
| 148 |
EPV034/#116 Predicting the rate of adjuvant postoperative chemo/radiation of patients with the recently updated stage IB2 cervical cancer: an Israeli gynecologic oncology group study
|
Gemer, O.
|
|
|
31 |
S4 |
p. A42-A43
|
artikel
|
| 149 |
EPV029/#569 Predictive factors of total response to neoadjuvant chemotherapy (NAT) in breast cancer patients: a restrospective observational study
|
Bouhani, M.
|
|
|
31 |
S4 |
p. A40-A41
|
artikel
|
| 150 |
EPV066/#382 Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101: an open-label, single arm, phase II clinical trial
|
Zou, D.
|
|
|
31 |
S4 |
p. A55
|
artikel
|
| 151 |
EPV206/#481 Preoperative evaluation of adnexal mass in breast cancer patients
|
Ennes, A.
|
|
|
31 |
S4 |
p. A111
|
artikel
|
| 152 |
EPV256/#150 Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: a systematic review
|
Di Donato, V.
|
|
|
31 |
S4 |
p. A130
|
artikel
|
| 153 |
EPV113/#323 Prognostic factors and oncologic outcomes for patients treated with adjuvant chemotherapy and vaginal vault brachytherapy for stage I endometrial serous carcinomas
|
Dorion, V.
|
|
|
31 |
S4 |
p. A75
|
artikel
|
| 154 |
EPV190/#320 Prognostic impact of PD-L1 expression in epithelial ovarian cancer: a cohort of 49 patients
|
Atallah, D.
|
|
|
31 |
S4 |
p. A104-A105
|
artikel
|
| 155 |
EPV210/#490 Prognostic implications of hemodynamic instability during ovarian cancer surgery
|
Kim, J.
|
|
|
31 |
S4 |
p. A112-A113
|
artikel
|
| 156 |
EPV098/#177 Prospects for improving the methods of complex treatment of patients with endometrial cancer stage I
|
Movchan, O.
|
|
|
31 |
S4 |
p. A68-A69
|
artikel
|
| 157 |
EPV067/#391 Quality control in early stage cervical cancer management: a single-institution’s experience
|
Shim, J.E.
|
|
|
31 |
S4 |
p. A55-A56
|
artikel
|
| 158 |
EPV231/#271 Quality of life after treatment for granulosa cell tumor
|
Darnell, G.
|
|
|
31 |
S4 |
p. A120
|
artikel
|
| 159 |
EPV203/#449 ‘Quick’ laparoscopy for suspected advanced ovarian cancer
|
Taumberger, N.
|
|
|
31 |
S4 |
p. A110
|
artikel
|
| 160 |
EPV042/#199 Racial and regional disparities in the diagnosis of advanced stage cervical cancers in the US: who is most at risk?
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A46
|
artikel
|
| 161 |
EPV247/#348 Racial disparities in ovarian cancer survival in the United States despite adherence to national guideline care
|
Sussell, J.
|
|
|
31 |
S4 |
p. A126
|
artikel
|
| 162 |
EPV249/#482 Racial disparities in the completion of the hpv vaccination series in women in the United States – a 9-year study
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A127
|
artikel
|
| 163 |
EPV035/#138 Radical trachelectomy. Experience in Kazior
|
Satanova, A.
|
|
|
31 |
S4 |
p. A43
|
artikel
|
| 164 |
EPV222/#603 Radiological response to neoadjuvant chemotherapy as indicator of optimal cytoreduction in advanced ovarian cancer
|
Maricic, S.
|
|
|
31 |
S4 |
p. A117
|
artikel
|
| 165 |
EPV068/#398 Randomized controlled trial of the efficacy of adjuvant chemotherapy in patients with residual lesions after concurrent chemoradiation therapy for locally advanced cervical cancer (CQGOG0102)
|
He, M.
|
|
|
31 |
S4 |
p. A56
|
artikel
|
| 166 |
EPV070/#401 Randomized controlled trial of the efficacy of lymph node dissection on stage IIICR of cervical cancer (CQGOG0103)
|
He, M.
|
|
|
31 |
S4 |
p. A57
|
artikel
|
| 167 |
EPV201/#44 Real-world data analysis of second-line poly (ADP-RIBOSE) polymerase inhibitor maintenance therapy in patients with advanced ovarian cancer
|
Reid, R.
|
|
|
31 |
S4 |
p. A109
|
artikel
|
| 168 |
EPV232/#585 Relational agents in cervical cancer education: a pilot study to determine acceptability and impact of interactive education on vaccine advocacy
|
Spencer, E.
|
|
|
31 |
S4 |
p. A120-A121
|
artikel
|
| 169 |
EPV039/#175 Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer
|
Cherston, C.
|
|
|
31 |
S4 |
p. A44-A45
|
artikel
|
| 170 |
EPV016/#272 Resilience in breast cancer patients and its association with anxiety and depression
|
Sghaier, S.
|
|
|
31 |
S4 |
p. A36
|
artikel
|
| 171 |
EPV143/#656 Retrospective data analysis of hospital santa marcelina, Sao Paulo-SP, Brazil
|
Mesquita, M.
|
|
|
31 |
S4 |
p. A87
|
artikel
|
| 172 |
EPV087/#57 Retrospective review of the management of the paraaortic region in patients diagnosed with cervical cancer referred for definitive pelvic external beam radiotherapy
|
Callueng, J.M.
|
|
|
31 |
S4 |
p. A63-A64
|
artikel
|
| 173 |
EPV123/#437 Risk of leiomyosarcoma in patients undergoing hysterectomy for presumed benign disease
|
Longo, M.
|
|
|
31 |
S4 |
p. A79
|
artikel
|
| 174 |
EPV099/#179 Robotic-assisted surgery for endometrial cancer in morbidly and extremely morbidly obese patients
|
Lechartier, C.
|
|
|
31 |
S4 |
p. A69
|
artikel
|
| 175 |
EPV065/#372 Role for neoadjuvant chemotherapy and less invasive surgery in management of early stage cervical cancer in Botswana
|
Tuli, S.
|
|
|
31 |
S4 |
p. A54-A55
|
artikel
|
| 176 |
EPV006/#578 Role of chronic stress on anti-tumor T-cell responses in ovarian cancer
|
Aquino-Acevedo, A.
|
|
|
31 |
S4 |
p. A32
|
artikel
|
| 177 |
EPV084/#549 Role of dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in locally advanced cervical cancer
|
Multinu, F.
|
|
|
31 |
S4 |
p. A62-A63
|
artikel
|
| 178 |
EPV008/#139 Role of KI67 in predicting survival in RH+/HER2- breast cancer according to axillary nodal involvement
|
Mejri, N.
|
|
|
31 |
S4 |
p. A33
|
artikel
|
| 179 |
EPV268/#642 Role of robotic surgery for interval debulking of ovarian cancer after neoadjuvant chemotherapy
|
Press, J.
|
|
|
31 |
S4 |
p. A135
|
artikel
|
| 180 |
EPV082/#511 Routine pelvic lymph node frozen section examination in preventing ineffective dual modality management in early-stage cervical cancer
|
Pappa, C.
|
|
|
31 |
S4 |
p. A61-A62
|
artikel
|
| 181 |
EPV272/#115 Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: a pilot project
|
Mitric, C.
|
|
|
31 |
S4 |
p. A137
|
artikel
|
| 182 |
EPV260/#451 Schwannoma of the pudendal nerve – anatomical considerations in the approach to surgical management of this rare pathology
|
Smyth, S.
|
|
|
31 |
S4 |
p. A131-A132
|
artikel
|
| 183 |
EPV001/#119 Screening and identification of novel chemotherapy agents in platinum-resistant ovarian cancer
|
Schweer, D.
|
|
|
31 |
S4 |
p. A29-A30
|
artikel
|
| 184 |
EPV202/#446 Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?
|
Laven, P.
|
|
|
31 |
S4 |
p. A109-A110
|
artikel
|
| 185 |
EPV138/#609 Sentinel lymph-node in aged endometrial cancer patients ‘the sage study’: a multicenter experience
|
Rosati, A.
|
|
|
31 |
S4 |
p. A85
|
artikel
|
| 186 |
EPV081/#509 Sentinel lymph node mapping using intra-abdominal indocyanine green injection in open surgery for cervical cancer: a novel technique of indocyanine green injection by abdominal approach
|
Kim, Y.M.
|
|
|
31 |
S4 |
p. A61
|
artikel
|
| 187 |
EPV252/#67 Sentinel node mapping in endometrial cancer using hysteroscopic injection of indocyanine green and near-infrared fluorescence imaging
|
Bogani, G.
|
|
|
31 |
S4 |
p. A128
|
artikel
|
| 188 |
EPV254/#148 Septuagenarians and octogenarians undergoing gynecologic oncology laparotomy: is there a role for routine postoperative cardiac biomarker monitoring?
|
Anpalagan, T.
|
|
|
31 |
S4 |
p. A129
|
artikel
|
| 189 |
EPV026/#548 Sexuality after breast cancer surgery in postmenopausal women
|
Kaabia, O.
|
|
|
31 |
S4 |
p. A40
|
artikel
|
| 190 |
EPV230/#122 Sexual orientation and gender identity reporting in oncology patients
|
Hughes-Hogan, L.
|
|
|
31 |
S4 |
p. A120
|
artikel
|
| 191 |
EPV020/#311 Sigmoid colon metastasis from medullary breast carcinoma mimicking primary sigmoid colon cancer
|
Bouaziz, H.
|
|
|
31 |
S4 |
p. A37
|
artikel
|
| 192 |
EPV281/#407 Single-dose methotrexate in the treatment of low-risk gestational trophoblastic neoplasia – an updated Results
|
Ngu, S.F.
|
|
|
31 |
S4 |
p. A140
|
artikel
|
| 193 |
EPV051/#264 Small cell neuroendocrine carcinoma of the cervix in a young patient with uterine procidentia: a case report
|
Garcia, M.
|
|
|
31 |
S4 |
p. A49-A50
|
artikel
|
| 194 |
EPV215/#519 SOX4 drives ovarian cancer stemness via transcriptionally activating HDAC1
|
Liu, J.
|
|
|
31 |
S4 |
p. A114
|
artikel
|
| 195 |
EPV265/#550 Strategies to minimise major blood loss in pelvic surgery – pelvic vasculature interventions
|
Downing, C.
|
|
|
31 |
S4 |
p. A134
|
artikel
|
| 196 |
EPV243/#63 Surgical and adjuvant treatments for uterine pecoma
|
Bogani, G.
|
|
|
31 |
S4 |
p. A125
|
artikel
|
| 197 |
EPV276/#532 Surgical menopause: effect of estrogen-progesterone and testosterone replacement therapy on psychological well-being and sexual functioning: a systematic literature review
|
Stuursma, A.
|
|
|
31 |
S4 |
p. A138
|
artikel
|
| 198 |
EPV257/#152 Surgical site infiltration versus transversus abdominis plane block of liposomal bupivacaine after midline vertical laparotomy for gynecologic malignancy: a prospective randomized controlled trial
|
Moon, A.
|
|
|
31 |
S4 |
p. A130
|
artikel
|
| 199 |
EPV287/#539 Surgical treatment of vulvar carcinoma in very elderly Italian population: a retrospective study
|
Falcicchio, G.
|
|
|
31 |
S4 |
p. A142
|
artikel
|
| 200 |
EPV212/#496 Survival impact of internal mammary or supraclavicular lymphadenectomy on stage ivb ovarian cancer with supradiaphragmatic lymph node metastasis
|
Park, S.J.
|
|
|
31 |
S4 |
p. A113
|
artikel
|
| 201 |
EPV209/#49 Survival in case of cardiophrenic lymphadenopathy in advanced stage epithelial ovarian cancer patients who underwent cytoreductive surgery; a systematic review and meta- analysis
|
Kengsakul, M.
|
|
|
31 |
S4 |
p. A112
|
artikel
|
| 202 |
EPV140/#62 Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping plus back-up lymphadenectomy and sentinel node mapping alone
|
Bogani, G.
|
|
|
31 |
S4 |
p. A86
|
artikel
|
| 203 |
EPV072/#413 Suture granuloma mimicking stage ib1 cervical cancer recurrence on vesical-uterine space after radical trachelectomy
|
Carvalho De Cillo, P.E.
|
|
|
31 |
S4 |
p. A58
|
artikel
|
| 204 |
EPV069/#40 Systematic comparison of international treatment guidelines for locally advanced cervical cancer
|
Pujade-Lauraine, E.
|
|
|
31 |
S4 |
p. A56-A57
|
artikel
|
| 205 |
EPV193/#344 Systematic review and meta-analysis of the survival impact of secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma
|
Goldberg, R.
|
|
|
31 |
S4 |
p. A106
|
artikel
|
| 206 |
EPV189/#277 Temporal trends of healthcare system costs and utilization related to ovarian cancer diagnosis in the United States
|
Huepenbecker, S.
|
|
|
31 |
S4 |
p. A104
|
artikel
|
| 207 |
EPV171/#106 The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: a systematic review and meta-analysis
|
Van De Vorst, R.
|
|
|
31 |
S4 |
p. A97
|
artikel
|
| 208 |
EPV208/#485 The clinical demand for pressurized intraperitoneal aerosol chemotherapy in south korea: an electronic survey-based study
|
Lee, E.J.
|
|
|
31 |
S4 |
p. A112
|
artikel
|
| 209 |
EPV223/#608 The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis
|
Lof, P.
|
|
|
31 |
S4 |
p. A117-A118
|
artikel
|
| 210 |
EPV284/#238 The early detection of vulvar cancer through self-examination (educate) study: what women and clinicians think
|
Sivalingam, V.N.
|
|
|
31 |
S4 |
p. A141
|
artikel
|
| 211 |
EPV180/#191 The feasibility and efficacy of pembrolizumab in combination with chemotherapy in patients undergoing frontline treatment of ovarian cancer
|
How, J.
|
|
|
31 |
S4 |
p. A100
|
artikel
|
| 212 |
EPV205/#458 The follow up management of borderline ovarian tumours: a 10-year experience
|
Wood, C.
|
|
|
31 |
S4 |
p. A110-A111
|
artikel
|
| 213 |
EPV246/#242 The gender imbalance in gynecologic oncology authorship and editorial boards
|
Mah, S.J.
|
|
|
31 |
S4 |
p. A126
|
artikel
|
| 214 |
EPV055/#292 The higher incidence of cervical cancer among hispanics in the US: what factors are responsible?
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A51
|
artikel
|
| 215 |
EPV158/#447 The IGCS project echo virtual tumor board: review of a pathologist’s experience from the first 2 years
|
Olkhov-Mitsel, E.
|
|
|
31 |
S4 |
p. A92
|
artikel
|
| 216 |
EPV063/#357 The impact of surgical approach in cases with no residual disease on hysterectomy specimen: a 4C (Canadian cervical cancer collaborative) working group study
|
Aubrey, C.
|
|
|
31 |
S4 |
p. A54
|
artikel
|
| 217 |
EPV033/#626 The impact of the COVID-19 pandemic on breast cancer patients awaiting surgery: the experience of salah azaiez institute Tunisia
|
Bouhani, M.
|
|
|
31 |
S4 |
p. A42
|
artikel
|
| 218 |
EPV118/#381 The increased incidence of uterine cancer with high risk histologies – a population study from the Taiwan cancer registry
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A77
|
artikel
|
| 219 |
EPV043/#200 The increasing incidence of metastatic cervical cancer in the United States – what factors are responsible?
|
Liao, C.-I.
|
|
|
31 |
S4 |
p. A46
|
artikel
|
| 220 |
EPV125/#443 The prevalence of uterus cancer in Uzbekistan
|
Djanklich, S.
|
|
|
31 |
S4 |
p. A80
|
artikel
|
| 221 |
EPV132/#552 The prognostic impact of lower uterine segment involvement in women with low-risk endometrial carcinoma: a multicenter study
|
Levin, G.
|
|
|
31 |
S4 |
p. A82
|
artikel
|
| 222 |
EPV040/#185 The prognostic value of the number of positive lymph nodes and the lymph node ratio in early stage cervical cancer
|
Olthof, E.
|
|
|
31 |
S4 |
p. A45
|
artikel
|
| 223 |
EPV144/#76 The Tunisian country-specific guidelines for endometrial cancer
|
Ghalleb, M.
|
|
|
31 |
S4 |
p. A87
|
artikel
|
| 224 |
EPV061/#345 The use of routine cytology following cervical cancer treatment: a call to discontinue the surveillance pap smear
|
Mcdowell, J.
|
|
|
31 |
S4 |
p. A53
|
artikel
|
| 225 |
EPV255/#120 Tisotumab vedotin vs investigator’s choice chemotherapy in second- or third-line recurrent or metastatic cervical cancer (innovatv 301/ENGOT-CX12/GOG-3057, trial in progress)
|
Vergote, I.
|
|
|
31 |
S4 |
p. A129-A130
|
artikel
|
| 226 |
EPV092/#74 Today’s preventable cancers: HPV vaccination knowledge and uptake in health professional graduate students (HPS)
|
Levy, M.
|
|
|
31 |
S4 |
p. A65-A66
|
artikel
|
| 227 |
EPV141/#627 Total hysterectomy for unexpected uterine leiomyosarcoma: impact of surgery on oncological outcomes
|
Lembo, A.
|
|
|
31 |
S4 |
p. A86
|
artikel
|
| 228 |
EPV139/#616 TP53 mutations differentially affect prognosis of endometrial cancer: an in-silico approach
|
Das Ghosh, D.
|
|
|
31 |
S4 |
p. A85
|
artikel
|
| 229 |
EPV048/#252 Transition from FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; does the revised staging correctly reflect risk groups?
|
Sponholtz, S.
|
|
|
31 |
S4 |
p. A48
|
artikel
|
| 230 |
EPV286/#444 Trends in morbidity of vulvar cancer in Uzbekistan
|
Djanklich, S.
|
|
|
31 |
S4 |
p. A142
|
artikel
|
| 231 |
EPV192/#33 Trends of change in cancer morbidity for the ovarian cancer in uzbekistan
|
Djanklich, S.
|
|
|
31 |
S4 |
p. A106
|
artikel
|
| 232 |
EPV241/#390 Tumor size as a prognostic factor for mesonephric and mesonephric-like adenocarcinoma of the endometrium: a rare case series of 72 patients
|
Paik, H.
|
|
|
31 |
S4 |
p. A124
|
artikel
|
| 233 |
EPV253/#125 Two cases of obturator nerve complete transection during laparoscopic pelvic lymph node dissection for endometrial cancer
|
Mogami, T.
|
|
|
31 |
S4 |
p. A128-A129
|
artikel
|
| 234 |
EPV237/#541 Two-year effectiveness of topical imiquimod treatment of high-grade cervical intraepithelial neoplasia (TOPIC-3)
|
Hendriks, N.
|
|
|
31 |
S4 |
p. A122-A123
|
artikel
|
| 235 |
EPV044/#201 Understanding the never-screened population for cervical cancer in the United States – a descriptive and trend analysis
|
Francoeur, A.
|
|
|
31 |
S4 |
p. A46-A47
|
artikel
|
| 236 |
EPV126/#448 Undifferentiated and dedifferentiated carcinoma of the endometrium: clinicopathologic features and implications for prognostication and management
|
Mah, S.J.
|
|
|
31 |
S4 |
p. A80
|
artikel
|
| 237 |
EPV015/#266 Use of fluorescence for sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer
|
Kaabia, O.
|
|
|
31 |
S4 |
p. A35
|
artikel
|
| 238 |
EPV100/#181 Uterine carcinosarcoma: a multicentre review of treatment and outcomes over 26 years
|
Yim, C.
|
|
|
31 |
S4 |
p. A69
|
artikel
|
| 239 |
EPV112/#318 Uterine carcinosarcoma following tamoxifen therapy for breast cancer: a series of 11 cases
|
Ben Hamida, K.
|
|
|
31 |
S4 |
p. A74-A75
|
artikel
|
| 240 |
EPV288/#61 Verrucous carcinoma of the vulva: patterns of care and treatment outcomes
|
Dryden, S.
|
|
|
31 |
S4 |
p. A142-A143
|
artikel
|
| 241 |
EPV128/#510 Womb cancer risk awareness: developing tools to influence change
|
Jones, O.
|
|
|
31 |
S4 |
p. A81
|
artikel
|
| 242 |
O010/#784 Adjuvant chemotherapy following chemo-radiation as primary treatment for locally advanced cervical cancer compared to chemo-radiation alone: the randomised phase 3 outback trial
|
Moore, K.
|
|
|
31 |
S4 |
p. A6
|
artikel
|
| 243 |
O008/#785 A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
|
Makker, V.
|
|
|
31 |
S4 |
p. A4-A5
|
artikel
|
| 244 |
O003/#149 Antitumor activity of dostarlimab in patients with advanced or recurrent mismatch repair–deficient or proficient–cancer by prior therapy: results from the garnet study
|
Oaknin, A.
|
|
|
31 |
S4 |
p. A2
|
artikel
|
| 245 |
O016/#233 Clinical and molecular characteristics of ariel3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC)
|
Coleman, R.L.
|
|
|
31 |
S4 |
p. A10
|
artikel
|
| 246 |
O015/#436 Comprehensive genomic profiling of low-grade serous cancers and associated clinical outcomes
|
Manning-Geist, B.
|
|
|
31 |
S4 |
p. A8-A9
|
artikel
|
| 247 |
O004/#393 Does intensive follow-up improve overall survivalin endometrial cancer patients? Results from the totem randomized controlled trial
|
Zola, P.
|
|
|
31 |
S4 |
p. A2-A3
|
artikel
|
| 248 |
O017/#15 Efficacy and safety of niraparib maintenance treatment in platinum-sensitive recurrent ovarian cancer after shorter or longer chemotherapy: a post hoc subgroup analysis
|
Gao, Y.
|
|
|
31 |
S4 |
p. A10-A11
|
artikel
|
| 249 |
O014/#828 Efficacy and safety of socazolimab in recurrent or metastatic cervical cancer: results from the phase I trial followed by an expansion study
|
An, J.
|
|
|
31 |
S4 |
p. A8
|
artikel
|
| 250 |
O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma
|
Tewari, K.
|
|
|
31 |
S4 |
p. A1
|
artikel
|
| 251 |
O006/#340 Minimally invasive surgery in advanced endometrial carcinoma is associated with an increased risk for local recurrence
|
Kogan, L.
|
|
|
31 |
S4 |
p. A3-A4
|
artikel
|
| 252 |
O012/#207 Multi-omics characterization of molecular features correlated to perineural invasion in cervical cancer
|
Wan, T.
|
|
|
31 |
S4 |
p. A7
|
artikel
|
| 253 |
OP004/#35 BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
|
Bogani, G.
|
|
|
31 |
S4 |
p. A12
|
artikel
|
| 254 |
OP019/#123 Clear cell ovarian cancer in native Asians compared to us Asians – is there a difference?
|
Tunnage, I.
|
|
|
31 |
S4 |
p. A19
|
artikel
|
| 255 |
OP009/#222 Combined oral megestrol acetate/levonorgestrel-intrauterine system for atypical endometrial hyperplasia: a single-center prospective randomized controlled pilot study
|
Xu, Z.
|
|
|
31 |
S4 |
p. A14
|
artikel
|
| 256 |
OP023/#658 Correlation of hrd status with clinical and survival outcomes in patients with advanced-stage ovarian cancer undergoing frontline and maintenance therapy
|
Sims, T.
|
|
|
31 |
S4 |
p. A20-A21
|
artikel
|
| 257 |
OP013/#417 Cost-effectiveness of dostarlimab in advanced recurrent deficient mismatch repair endometrial cancer patients
|
Dioun, S.
|
|
|
31 |
S4 |
p. A16
|
artikel
|
| 258 |
OP027/#469 Electronic patient-reported outcome (EPRO) measures in gynecologic oncology: initial experience after workflow implementation
|
Noh, J.
|
|
|
31 |
S4 |
p. A22
|
artikel
|
| 259 |
OP017/#81 Endometrial cancer prognosis in women with endometriosis and adenomyosis. A retrospective nationwide cohort study of 40,847 women
|
Hermens, M.
|
|
|
31 |
S4 |
p. A18
|
artikel
|
| 260 |
OP010/#223 Extrapelvic recurrence risk in women who underwent minimally-invasive versus open laparotomy for intermediate-risk endometrial cancer; a multi-center review
|
Dedinca, A.
|
|
|
31 |
S4 |
p. A15
|
artikel
|
| 261 |
OP024/#182 Findings and outcomes in a post-vaccination cohort of young women under 25 years attending a tertiary colposcopy service
|
Yim, C.
|
|
|
31 |
S4 |
p. A21
|
artikel
|
| 262 |
OP015/#492 Further stratification of no specific molecular profile (NSMP/P53WT) endometrial carcinomas to refine prognosis and identify therapeutic opportunities
|
Thompson, E.
|
|
|
31 |
S4 |
p. A17
|
artikel
|
| 263 |
OP020/#524 Heath care resource and cost implications of integration of molecular classification in the management of endometrial cancer
|
Hanley, G.
|
|
|
31 |
S4 |
p. A19
|
artikel
|
| 264 |
OP002/#213 Is cervical excision before radical hysterectomy associated with better oncologic outcomes for patients with early stage cervical carcinoma ?
|
Nasioudis, D.
|
|
|
31 |
S4 |
p. A12
|
artikel
|
| 265 |
OP026/#45 Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: analysis using the national surgical quality improvement program (NSQIP) database
|
Goins, E.
|
|
|
31 |
S4 |
p. A21-A22
|
artikel
|
| 266 |
OP012/#257 Minimally invasive surgery is associated with an increased risk for local recurrence in high-grade endometrial carcinoma
|
Levin, G.
|
|
|
31 |
S4 |
p. A15-A16
|
artikel
|
| 267 |
OP016/#563 Morbidity and quality of life of sentinel lymph node mapping in endometrial cancer. Interim analysis of a prospective randomized trial (ALICE trial)
|
Goncalves, B.
|
|
|
31 |
S4 |
p. A17-A18
|
artikel
|
| 268 |
OP008/#194 P53ABN molecular subtype encompasses a morphologically diverse subset of endometrial cancers and identifies therapeutic opportunities to improve outcomes
|
Jamieson, A.
|
|
|
31 |
S4 |
p. A14
|
artikel
|
| 269 |
OP007/#276 Phase I study of mirvetuximab soravtansine (MIRV) and rucaparib for recurrent endometrial, ovarian, fallopian tube or primary peritoneal cancer
|
Backes, F.
|
|
|
31 |
S4 |
p. A13-A14
|
artikel
|
| 270 |
OP011/#250 Postmenopausal status and elevated serum level of cancer antigen 125 significantly predicted concurrent endometrial cancer in women diagnosed with atypical endometrial hyperplasia before surgery
|
Lou, Y.-C.
|
|
|
31 |
S4 |
p. A15
|
artikel
|
| 271 |
OP003/#32 Preferences and experiences regarding the use of the self-sampling device in the hrHPV screening for cervical cancer
|
Dieleman, M.
|
|
|
31 |
S4 |
p. A12
|
artikel
|
| 272 |
OP018/#414 Progression free survival and overall survival after BRCA1/2-ASSOCIATED epithelial ovarian cancer: a matched cohort study
|
Heemskerk-Gerritsen, B.
|
|
|
31 |
S4 |
p. A18-A19
|
artikel
|
| 273 |
O011/#287 Prognostic significance of ‘p53 signature’ (fields of dysplasia) and in situ margin status in organ-confined HPV-independent p53 abnormal vulvar squamous cell carcinoma
|
Thompson, E.
|
|
|
31 |
S4 |
p. A6-A7
|
artikel
|
| 274 |
OP005/#352 Safety of vaginal hysterectomy for cervical cancer: a multicenter cohort study on behalf of the 4C (Canadian cervical cancer collaborative) working group
|
Cockburn, N.
|
|
|
31 |
S4 |
p. A13
|
artikel
|
| 275 |
OP001/#162 Sentinel lymph node mapping in early-stage cervical cancer – a national prospective multicenter study (sentirec trial)
|
Sponholtz, S.
|
|
|
31 |
S4 |
p. A11
|
artikel
|
| 276 |
OP021/#475 Separating the BRCA1 and BRCA2 phenotype, a pathway analysis
|
Rubinsak, L.
|
|
|
31 |
S4 |
p. A20
|
artikel
|
| 277 |
OP006/#489 Survival impact of ontogenetic surgery for newly diagnosed cervical cancer
|
Kim, U.
|
|
|
31 |
S4 |
p. A13
|
artikel
|
| 278 |
OP014/#480 Targeted molecular testing in endometrial carcinoma: validation of a restricted testing protocol
|
Talhouk, A.
|
|
|
31 |
S4 |
p. A16-A17
|
artikel
|
| 279 |
O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors
|
Makker, V.
|
|
|
31 |
S4 |
p. A1-A2
|
artikel
|
| 280 |
O007/#202 Recurrence and survival after laparoscopy versus laparotomy in early-stage endometrial cancer: long-term outcomes of a randomised trial
|
Van Suijlichem, M.
|
|
|
31 |
S4 |
p. A4
|
artikel
|
| 281 |
O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study
|
Kristeleit, R.
|
|
|
31 |
S4 |
p. A5-A6
|
artikel
|
| 282 |
O013/#573 Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (R/MCC): phase 1B/2 engot-CX8/GOG-3024/innovaTV 205 study dose-escalation results
|
Monk, B.
|
|
|
31 |
S4 |
p. A7-A8
|
artikel
|
| 283 |
O005/#190 Where there is smoke, there is fire: understanding the implications of positive sentinel lymph nodes in endometrial cancer
|
Dinoi, G.
|
|
|
31 |
S4 |
p. A3
|
artikel
|
| 284 |
SF007/#206 A systematic approach for achieving optimal cytoreduction of locally advanced endometrial cancer by a robotic approach
|
Feuer, G.
|
|
|
31 |
S4 |
p. A24
|
artikel
|
| 285 |
SF008/#514 Extraperitoneal sentinel lymph node biopsy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) in patients with non-prolapsed uterus and low-risk endometrial cancer
|
Ju, Y.Y.
|
|
|
31 |
S4 |
p. A24-A25
|
artikel
|
| 286 |
SF022/#580 Identification of inguinal sentinel lymph nodes in recurrent vulvar melanoma
|
Knigin, D.
|
|
|
31 |
S4 |
p. A29
|
artikel
|
| 287 |
SF001/#65 Laparoendoscopic radical trachelectomy and pelvic lymphadenectomy without uterine manipulator
|
Lu, H.
|
|
|
31 |
S4 |
p. A22-A23
|
artikel
|
| 288 |
SF014/#370 Laparoscopic repair of obturator nerve injury at the time of pelvic lymphadenectomy
|
Linder, R.
|
|
|
31 |
S4 |
p. A26-A27
|
artikel
|
| 289 |
SF010/#77 Laparoscopic sentinel lymph node biopsy for stage I endometrial cancer: dual tracer method
|
Slimane, M.
|
|
|
31 |
S4 |
p. A25
|
artikel
|
| 290 |
SF018/#632 Maylard incision: a transverse incision for complex gynecologic surgery
|
Ferjaoui, M.A.
|
|
|
31 |
S4 |
p. A28
|
artikel
|
| 291 |
SF021/#830 Minimally invasive secondary cytoreductive surgery for hepato-renal recess isolated recurrence of serous endometrial cancer in brca1 mutated patient
|
Iacobelli, V.
|
|
|
31 |
S4 |
p. A28-A29
|
artikel
|
| 292 |
SF015/#465 Pelvic lymphadenectomy made easy – a stepwise technique for systematic pelvic lymph node dissection
|
Smyth, S.
|
|
|
31 |
S4 |
p. A27
|
artikel
|
| 293 |
SF017/#513 Preservation of left triple renal artery during laparoscopic para-aortic lymphadenectomy
|
Eom, J.M.
|
|
|
31 |
S4 |
p. A27
|
artikel
|
| 294 |
SF013/#236 Robotic approach for a total hysterectomy bilateral salpingo-oophorectomy and suction curettage of a 20-week size uterus with gestational trophoblastic neoplasia
|
Gupta, V.
|
|
|
31 |
S4 |
p. A26
|
artikel
|
| 295 |
SF002/#332 Sentinel lymph node mapping for cervical cancer: a practical illustration of using icg during a laparotomy
|
Burling, M.
|
|
|
31 |
S4 |
p. A23
|
artikel
|
| 296 |
SF012/#204 10 steps to approach large ovarian masses through vnotes (vaginal natural transluminal endoscopic surgery)
|
Badiglian-Filho, L.
|
|
|
31 |
S4 |
p. A26
|
artikel
|
| 297 |
SF005/#192 Strategy for mis uterine manipulation in cervical carcinosarcoma
|
Simonsen, M.
|
|
|
31 |
S4 |
p. A24
|
artikel
|
| 298 |
SF004/#153 The use of lighted ureteral catheters in difficult minimally invasive gynecologic oncologic surgery
|
Mejia-Gomez, J.
|
|
|
31 |
S4 |
p. A23
|
artikel
|
| 299 |
SF003/#661 Total pelvic exenteration and perineal reconstruction for recurrent cervical cancer
|
Thomas, A.
|
|
|
31 |
S4 |
p. A23
|
artikel
|
| 300 |
SF006/#205 Upfront surgical management of large or necrotic malignant mixed mullerian tumors of the endometrium by a minimally invasive approach
|
Feuer, G.
|
|
|
31 |
S4 |
p. A24
|
artikel
|
| 301 |
SF020/#652 Use of a vaginally adapted gamma probe in the videolaparoscopic sentinel lymph node research
|
Munhóz, A.
|
|
|
31 |
S4 |
p. A28
|
artikel
|
| 302 |
SF019/#636 Vascular injury in robot-assisted para-aortic lymphadenectomy
|
Hernandez, J.
|
|
|
31 |
S4 |
p. A28
|
artikel
|
Tijdschrift beschrijving